Complicated infections of skin and skin structures: when the infection is more than skin deep.
about
Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infectionsDeterminants of hospitalization for a cutaneous injection-related infection among injection drug users: a cohort studyIn vitro activity and killing effect of citropin 1.1 against gram-positive pathogens causing skin and soft tissue infections.Skin and soft tissue infections in the intensive care unit: a retrospective study in a tertiary care centerAntibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline.Resistance and the management of complicated skin and skin structure infections: the role of ceftobiprole.Ionic liquids as a class of materials for transdermal delivery and pathogen neutralization.Hyaluronan breakdown contributes to immune defense against group A StreptococcusCurrent concepts in the management of necrotizing fasciitis.Analysis of the transcriptome of group A Streptococcus in mouse soft tissue infectionClinical and molecular characteristics of invasive and noninvasive skin and soft tissue infections caused by group A StreptococcusA randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infectionsCeftaroline in the management of complicated skin and soft tissue infections and community acquired pneumonia.Ceftaroline in complicated skin and skin-structure infections.Necrotizing fasciitis: literature review of contemporary strategies for diagnosing and management with three case reports: torso, abdominal wall, upper and lower limbsMeropenem in the treatment of complicated skin and soft tissue infectionsCANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections.Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycinDirect molecular versus culture-based assessment of Gram-positive cocci in biopsies of patients with major abscesses and diabetic foot infectionsNecrotizing fasciitis resulting from human bites: A report of two cases of disease caused by group A streptococcusUse of Oritavancin in Acute Bacterial Skin and Skin Structure Infections Patients Receiving Intravenous Antibiotics: A US Hospital Budget Impact AnalysisTigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections.In vitro activity of daptomycin & linezolid against methicillin resistant Staphylococcus aureus & vancomycin resistant enterococci isolated from hospitalized cases in Central India.The evaluation and treatment of complicated skin and skin structure infections.Skin and skin structure infections: treatment with newer generation fluoroquinolones.The effect of an emollient with benfothiamine and Biolin prebiotic on the improvement of epidermal skin function.Resistance profiles in surgical-site infection.Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections.Empirical antibiotics use in soft tissue infections.Inflammation and the host response to injury, a large-scale collaborative project: patient-oriented research core--standard operating procedures for clinical care VII--Guidelines for antibiotic administration in severely injured patients.Complicated skin and soft tissue infection.Soft tissue infections caused by marine bacterial pathogens: epidemiology, diagnosis, and management.Bacterial skin and soft tissue infections: review of the epidemiology, microbiology, aetiopathogenesis and treatment: a collaboration between dermatologists and infectivologists.Management of necrotizing skin and soft tissue infections.Antibacterial potential of northeastern Portugal wild plant extracts and respective phenolic compounds.Genetic Variation in TLR10, an Inhibitory Toll-Like Receptor, Influences Susceptibility to Complicated Skin and Skin Structure Infections.Gangrene and bacteremia due to Corynebacterium jeikeium in a patient on maintenance hemodialysis.In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infectionsEfficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized studyChemical myofascial necrosis: a rare complication of laparoscopic nephrectomy.
P2860
Q24672937-8CD440FE-374B-4618-9F55-883BEC5534CCQ33599370-AEBB054A-5E09-45EC-BC78-C7838F8149DFQ33836677-48EEC1EB-1BFF-48CA-A473-7A3F5E09688BQ33870305-1F783C1A-CA46-4F7C-9DC3-2A7C995FBD64Q34133346-E7C689BD-159E-4FE7-BFDC-E7305C66128AQ34187667-A0FF1732-75F2-4F09-AFC1-F6070BFD0493Q34218220-D844D5FD-F3FC-4392-9A62-C2C9F8E5FB22Q34245010-3CF88759-B21E-4A17-8955-9771E999B7A7Q34868108-E850052E-98C2-4990-8991-44F6AC906575Q35222098-8D818377-67A4-4C8C-93E5-650AEF913B6BQ35273594-385DE070-04FB-47BD-9C71-C624BF656E65Q35328383-09E7978E-074F-4712-B724-DA5E9A74047EQ35408518-3498F4C4-12DE-4AA3-9E14-C3EDD3B7B7ABQ35715381-9F31ED3B-7BD3-415F-9DEA-BCFECA45ACD0Q35847927-2BB7F834-80CC-4A8C-B08E-7B0456218587Q35919254-E137B88A-0F0E-42A4-928F-D7B278F03A23Q35941227-A4CB223D-2454-425B-A057-A6451DE8D8D7Q35959558-BF0EA139-0F83-4E42-9F01-6537D6BCC337Q35983355-017D0986-9CFB-40FB-9675-24A43EF3EE16Q36171077-46492D19-9B2B-4993-972B-E6688D4AC256Q36541737-A7266FDF-B5D4-4400-8072-FFE3563C68B1Q36663656-7756A1AA-E7E0-4B1A-B6D0-F8C20D4B1A9EQ36855598-590AC3C7-A144-4E8A-852A-63898B889225Q37111836-D23B2A94-6D62-48C7-86A9-EADD64CEFB5DQ37116838-107AD37A-B0C7-45EF-85A9-A0001B180E01Q37143992-2DEDF37B-D1C5-4E7E-B70B-ECF6EBC06899Q37225677-FC18962F-5643-4783-BD16-C1863874E903Q37593094-165A0732-E790-4F09-8926-58D7DD637678Q37641770-5588325C-A7D8-41A9-B6A1-F9217BFA76B8Q37731193-73F372C8-0A32-4970-8A8B-1A9AF68AA315Q37793714-D56EC7D1-7322-4CE0-A6CC-CB246CA34C7BQ37904804-025E0D28-19FD-4720-B78D-053BAEE3935AQ37972892-FBE9B92D-0517-441F-B28E-7884B76AE08FQ38040153-862992AD-73C9-4C04-AFBF-E9ECCABB380EQ41223803-9412C5C1-116F-4432-A483-7D482BE832FEQ41304611-6C9F5A6A-6489-46AD-8914-F7EC41AB2D4DQ41605031-9DCA550D-5D92-4125-885B-9B838CB450D1Q42444666-24DD3A40-2793-4552-A3E5-162179005FC7Q43694841-A4B9AC5F-3F81-486D-A902-05CDDB496271Q43906026-DE6C03D3-40C8-4EA5-B7A1-A7842D62EEFB
P2860
Complicated infections of skin and skin structures: when the infection is more than skin deep.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Complicated infections of skin ...... ection is more than skin deep.
@ast
Complicated infections of skin ...... ection is more than skin deep.
@en
Complicated infections of skin ...... ection is more than skin deep.
@nl
type
label
Complicated infections of skin ...... ection is more than skin deep.
@ast
Complicated infections of skin ...... ection is more than skin deep.
@en
Complicated infections of skin ...... ection is more than skin deep.
@nl
prefLabel
Complicated infections of skin ...... ection is more than skin deep.
@ast
Complicated infections of skin ...... ection is more than skin deep.
@en
Complicated infections of skin ...... ection is more than skin deep.
@nl
P356
P1476
Complicated infections of skin ...... ection is more than skin deep.
@en
P2093
Mark J DiNubile
P304
P356
10.1093/JAC/DKH202
P407
P478
53 Suppl 2
P577
2004-06-01T00:00:00Z